Published in:
Volume 4 / Year 2015 / Issue 1

Biosimilars: patient and physician acceptability is the fifth hurdle to market competition

Page: 6-7

Abstract: Biosimilar products confront novel market authorization and post-marketing use hurdles. Existing evidence is insufficient to fully address physician and payer acceptability thresholds. Submitted: 4 March 2015; Revised: 5 March… Read More »

Go Back Print